Heartflow (HTFL) Stock Price, News & Analysis

Company Overview

HeartFlow, Inc. (NASDAQ: HTFL) is a digital health company headquartered in Redwood City, California, that specializes in non-invasive diagnostic solutions for coronary artery disease. Its flagship offering, HeartFlow Analysis, applies advanced computational fluid dynamics and deep learning algorithms to standard coronary CT angiography images. By reconstructing a patient’s 3D arterial anatomy and quantifying fractional flow reserve (FFRCT), the technology provides clinicians with personalized insights into blood flow reduction and lesion-specific ischemia without the need for invasive catheterization.

HeartFlow’s cloud-based platform streamlines the diagnostic workflow by securely transmitting CT image data to its analysis center, where engineers and data scientists generate a detailed physiological assessment. The resulting HeartFlow Analysis report integrates seamlessly with existing imaging systems and offers interactive visualizations that help cardiologists and radiologists prioritize treatment pathways. This capability supports clinical decision-making across diagnostic centers, hospitals and specialized heart institutes.

Founded in 2010 by physicians and engineers from Stanford University, HeartFlow received FDA clearance for its FFRCT technology in 2014 and obtained CE mark approval for European markets shortly thereafter. The company launched a successful initial public offering in February 2021. Since its inception, HeartFlow has forged partnerships with major health systems, academic medical centers and research organizations to validate its technology in large-scale clinical trials and real-world studies.

HeartFlow’s services are available in the United States, Europe, Japan and select other markets, with plans to expand access through strategic collaborations and reimbursement agreements. Under the leadership of President and CEO John H. Stevens, the company continues to invest in research and development, aiming to broaden its digital cardiovascular portfolio and enhance early detection and management of coronary artery disease worldwide.

Key Stats

• Today's Range: $31.94 to $33.79
• 50-Day Range: N/A
• 52-Week Range: $26.56 to $36.68
• Volume: 1.49 million shs
• Average Volume: 383,364 shs
• Market Capitalization: $2.67 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $35.80
• Consensus Rating: Moderate Buy

HTFL Stock Analysis - Frequently Asked Questions

How have HTFL shares performed this year?

Heartflow's stock was trading at $33.69 at the start of the year. Since then, HTFL stock has decreased by 2.4% and is now trading at $32.88.

How were Heartflow's earnings last quarter?

Heartflow, Inc. (NASDAQ:HTFL) posted its quarterly earnings data on Friday, September, 19th. The company reported ($1.46) EPS for the quarter, missing the consensus estimate of ($0.20) by $1.26. The business earned $43.42 million during the quarter, compared to analysts' expectations of $43.20 million.

When did Heartflow IPO?

Heartflow (HTFL) raised $317 million in an initial public offering (IPO) on Friday, August 8th 2025. The company issued 16,666,667 shares at $19.00 per share.

When did the company's quiet period expire?

Heartflow's quiet period expired on Wednesday, September 17th. Heartflow had issued 16,666,667 shares in its public offering on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. During the company's quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Heartflow?

Shares of HTFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 9/19/2025
• Today: 9/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:HTFL
• Previous Symbol: NASDAQ:HTFL
• CIK: 1464521
• Web: www.heartflow.com
• Phone: 650 241 1221
• Fax: N/A
• Employees: 699
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Heartflow: $35.80
• High Price Target: $38.00
• Low Price Target: $35.00
• Potential Upside/Downside: +8.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 81,170,000
• Free Float: N/A
• Market Cap: $2.67 billion
• Optionable: N/A
• Beta: N/A